Ernexa Therapeutics to Participate in Virtual Investor Closing Bell Series
Ernexa Therapeutics will participate in the Virtual Investor Closing Bell Series on Thursday, October 15, 2026, at 4:00 PM ET. CEO Sanjeev Luther, CSO Dr. Robert Pierce, and SAB member Dr. Christopher Rohde will provide a corporate overview and business outlook, highlighting the company's cell therapy platform and lead candidate ERNA-101's advance toward clinical development.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.